DK175812B1 - Flydende præparat med forbedrede egenskaber til peroral administrering - Google Patents

Flydende præparat med forbedrede egenskaber til peroral administrering Download PDF

Info

Publication number
DK175812B1
DK175812B1 DK198803336A DK333688A DK175812B1 DK 175812 B1 DK175812 B1 DK 175812B1 DK 198803336 A DK198803336 A DK 198803336A DK 333688 A DK333688 A DK 333688A DK 175812 B1 DK175812 B1 DK 175812B1
Authority
DK
Denmark
Prior art keywords
oil
antibiotic
suspension according
liquid suspension
liquid
Prior art date
Application number
DK198803336A
Other languages
Danish (da)
English (en)
Other versions
DK333688A (da
DK333688D0 (da
Inventor
Seamus Mulligan
Original Assignee
Elan Corp Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Corp Plc filed Critical Elan Corp Plc
Publication of DK333688D0 publication Critical patent/DK333688D0/da
Publication of DK333688A publication Critical patent/DK333688A/da
Application granted granted Critical
Publication of DK175812B1 publication Critical patent/DK175812B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK198803336A 1987-06-19 1988-06-17 Flydende præparat med forbedrede egenskaber til peroral administrering DK175812B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE164587A IE59934B1 (en) 1987-06-19 1987-06-19 Liquid suspension for oral administration
IE164587 1987-06-19

Publications (3)

Publication Number Publication Date
DK333688D0 DK333688D0 (da) 1988-06-17
DK333688A DK333688A (da) 1988-12-20
DK175812B1 true DK175812B1 (da) 2005-03-07

Family

ID=11030020

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198803336A DK175812B1 (da) 1987-06-19 1988-06-17 Flydende præparat med forbedrede egenskaber til peroral administrering

Country Status (10)

Country Link
US (1) US5156842A (de)
EP (1) EP0295941B1 (de)
JP (1) JPS6416717A (de)
AT (1) ATE86851T1 (de)
CA (1) CA1314215C (de)
DE (1) DE3879286T2 (de)
DK (1) DK175812B1 (de)
ES (1) ES2054807T3 (de)
IE (1) IE59934B1 (de)
PH (1) PH24979A (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04506216A (ja) * 1989-06-13 1992-10-29 アボツト・ラボラトリーズ 薬物送達用の油を主成分とした非水性液体懸濁液
US5496535A (en) * 1991-04-12 1996-03-05 Alliance Pharmaceutical Corp. Fluorocarbon contrast media for use with MRI and radiographic imaging
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
US5650156A (en) * 1993-02-22 1997-07-22 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of nutriceuticals and compositions useful therefor
US6753006B1 (en) 1993-02-22 2004-06-22 American Bioscience, Inc. Paclitaxel-containing formulations
BR9405798A (pt) * 1993-02-22 1995-12-12 Vivorx Pharmaceuticals Inc Métodos para liberação in vivo de material biológico e composições úteis dos mesmos
US5665382A (en) * 1993-02-22 1997-09-09 Vivorx Pharmaceuticals, Inc. Methods for the preparation of pharmaceutically active agents for in vivo delivery
US5439686A (en) * 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
US5997904A (en) * 1993-02-22 1999-12-07 American Bioscience, Inc. Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US6528067B1 (en) 1993-02-22 2003-03-04 American Bioscience, Inc. Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
KR970702725A (ko) * 1994-04-26 1997-06-10 노부히로 나리따 비소세포 폐암 치료용 의약 조성물(Medicinal Composition as a Remedy for Nonsmall Cell Lung Cancer)
US5484800A (en) * 1994-08-30 1996-01-16 American Home Products Corporation Lipid-based liquid medicinal composition
SI9400338A (en) * 1994-08-31 1996-04-30 Lek D D Vancomycin hydrochloride suspensions for peroral use and for filling into soft ,gelatine capsules.
US5665386A (en) * 1995-06-07 1997-09-09 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
US5716928A (en) * 1995-06-07 1998-02-10 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
CA2224227A1 (en) * 1995-06-07 1996-12-19 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
US6949264B1 (en) 1996-11-27 2005-09-27 Wm. Wrigley Jr. Company Nutraceuticals or nutritional supplements and method of making
US5962522A (en) * 1997-09-05 1999-10-05 Avmax, Inc. Propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
US6180666B1 (en) 1997-09-05 2001-01-30 Anmax, Inc. Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds
BR9705470A (pt) * 1997-11-12 1999-07-06 Ind Quimica E Farmaceutica Sch Processo para a preparação de uma composição farmaceutica oral composição farmaceutica oral e kit compreendendo uma composição farmacêutica
US6627234B1 (en) 1998-12-15 2003-09-30 Wm. Wrigley Jr. Company Method of producing active agent coated chewing gum products
US7163705B2 (en) 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
US6586023B1 (en) 1998-12-15 2003-07-01 Wm. Wrigley Jr. Company Process for controlling release of active agents from a chewing gum coating and product thereof
US6531114B1 (en) 1999-04-06 2003-03-11 Wm. Wrigley Jr. Company Sildenafil citrate chewing gum formulations and methods of using the same
US6846495B2 (en) * 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
US6773716B2 (en) 1999-04-06 2004-08-10 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6355265B1 (en) 1999-04-06 2002-03-12 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6322806B1 (en) 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center
US7935362B2 (en) 1999-04-06 2011-05-03 Wm. Wrigley Jr. Company Over-coated product including consumable center and medicament
US6569472B1 (en) 2000-09-01 2003-05-27 Wm. Wrigley Jr. Company Coated chewing gum products containing antacid and method of making
US6663849B1 (en) 2000-09-01 2003-12-16 Wm. Wrigley Jr. Company Antacid chewing gum products coated with high viscosity materials
US6645535B2 (en) 1999-09-02 2003-11-11 Wm. Wrigley Jr. Company Method of making coated chewing gum products containing various antacids
US6541048B2 (en) 1999-09-02 2003-04-01 Wm. Wrigley Jr. Company Coated chewing gum products containing an acid blocker and process of preparing
US9387168B2 (en) 1999-09-20 2016-07-12 Jack Barreca Chewing gum with tomatidine
US9253991B2 (en) 1999-09-20 2016-02-09 Jack Barreca Chewing gum with B vitamins
AU3885201A (en) 1999-09-20 2001-04-24 Mastercare Diet and weight control gum and sucker
US7115288B2 (en) 2000-06-09 2006-10-03 Wm. Wrigley Jr. Company Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
US6572900B1 (en) 2000-06-09 2003-06-03 Wm. Wrigley, Jr. Company Method for making coated chewing gum products including a high-intensity sweetener
US6444241B1 (en) 2000-08-30 2002-09-03 Wm. Wrigley Jr. Company Caffeine coated chewing gum product and process of making
JP2004536026A (ja) * 2000-11-28 2004-12-02 トランスフォーム ファーマシューティカルズ，インコーポレーティッド． パクリタキセル、その誘導体、および薬剤として許容される塩を含む医薬品製剤
US6579545B2 (en) 2000-12-22 2003-06-17 Wm. Wrigley Jr. Company Coated chewing gum products containing an antigas agent
US20040092428A1 (en) * 2001-11-27 2004-05-13 Hongming Chen Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
US20040043073A1 (en) * 2002-06-14 2004-03-04 Chih-Ming Chen Pharmaceutical compositions for drugs having pH-dependent solubility
US20040202696A1 (en) * 2003-04-14 2004-10-14 Cts Chemical Industries Ltd. Administration form for veterinary use
GB0308732D0 (en) 2003-04-15 2003-05-21 Axcess Ltd Absorption enhancers
GB0308734D0 (en) 2003-04-15 2003-05-21 Axcess Ltd Uptake of macromolecules
PL1638529T3 (pl) * 2003-06-16 2017-03-31 Andrx Pharmaceuticals, Llc. Kompozycja doustna o przedłużonym uwalnianiu
WO2011107855A2 (en) 2010-03-04 2011-09-09 Torrent Pharmaceuticals Limited Sustained release oral liquid suspension dosage form
FR3000400B1 (fr) * 2012-12-27 2019-06-21 Virbac Suspension huileuse de metronidazole
US20170326161A1 (en) * 2015-12-10 2017-11-16 Imprimis Pharmaceuticals, Inc. Pharmaceutical formulations for treating skin disorders and methods for fabricating and using thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE567598A (de) *
JPS4971127A (de) * 1972-11-18 1974-07-10
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
US4181721A (en) * 1975-10-27 1980-01-01 Schering Aktiengesellschaft Depot preparations in an oily, unsaturated solution for intramuscular injection
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
DE3309763A1 (de) * 1983-03-18 1984-09-20 Bayer Ag Stabile aminoglykosid-penicillin-injektionsformulierungen
JPS60193914A (ja) * 1984-03-14 1985-10-02 Kao Corp 含粒油性薬剤組成物
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
FR2576213B1 (fr) * 1985-01-21 1989-02-24 Cortial Nouveau procede d'obtention de formes pharmaceutiques a liberation prolongee
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance

Also Published As

Publication number Publication date
IE871645L (en) 1988-12-19
CA1314215C (en) 1993-03-09
EP0295941A2 (de) 1988-12-21
EP0295941A3 (en) 1989-03-15
ES2054807T3 (es) 1994-08-16
JPS6416717A (en) 1989-01-20
IE59934B1 (en) 1994-05-04
DE3879286D1 (de) 1993-04-22
PH24979A (en) 1990-12-26
DK333688A (da) 1988-12-20
DK333688D0 (da) 1988-06-17
EP0295941B1 (de) 1993-03-17
DE3879286T2 (de) 1993-09-23
US5156842A (en) 1992-10-20
ATE86851T1 (de) 1993-04-15

Similar Documents

Publication Publication Date Title
DK175812B1 (da) Flydende præparat med forbedrede egenskaber til peroral administrering
KR910004573B1 (ko) 작용 지속형 세파클로르 제제의 제조 방법
KR950009097B1 (ko) 세푸록심 악세틸을 함유하는 제약 조성물
DE69014513T2 (de) System des Typs "einmal täglich" zur gepulsten Minocyclinabgabe.
US6136347A (en) Flavor-masked pharmaceutical compositions
US4765990A (en) Sustained-release nifedipine preparation
ES2435816T3 (es) Formulación farmacéutica que comprende una Beta-carbolina y su uso para el tratamiento de la disfunción sexual
EP0818992B1 (de) Verfahren zur verkapselung von nsaids
AT392901B (de) Verfahren zur herstellung einer granulaeren form mit verzoegerter freisetzung von pharmazeutisch wirksamen substanzen
EP0558913B1 (de) Verbessertes System des Typs einmal täglich zur gepulsten Minocyclinabgabe
CA1137414A (en) Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
EP0302900A1 (de) Arzneimittel mit unterdrücktem geschmack.
DK151608B (da) Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
US4960596A (en) Slow-release preparation of diltiazem, and a medicine provided thereby
FI96095C (fi) Menetelmä jatkuvavapautteisen lääkevalmisteen valmistamiseksi
NO177177B (no) Fremgangsmåte for fremstilling av en flytende doseringsform for oral administrasjon av en farmasöytisk substans
EP0164959A2 (de) Arzneimittel in Form einer Einheitsdosis mit verzögerter Freisetzung sowie Verfahren zu dessen Herstellung
GB2204241A (en) Fat coated pharmaceutical compositions
JP3285410B2 (ja) アントシアノシド類を含有する経口医薬組成物
JPS63188621A (ja) 矯味経口製剤
DE60006362T2 (de) Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen
IE62128B1 (en) Chewable medicament tablet containing means for taste masking
JP4060027B2 (ja) ビタミンｋ含有組成物
US4076804A (en) Erythromycin therapy
US4832955A (en) Controlled release potassium chloride composition

Legal Events

Date Code Title Description
PUP Patent expired